EP3423105
Samtengd mótefnis-lyfs-efnasambönd sem byggjast á eríbúlín og aðferðir til notkunar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
2.3.2017EP published:
5.5.2021EP application number:
17711475.8
EP translation filed:
5.7.2021Grant published:
15.8.2021EPO information:
European Patent Register
Max expiry date:
1.3.2037Expiry date:
1.3.2027Next due date:
31.3.2027
Title:
ERIBULIN-BASED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
Timeline
Today
2.3.2017EP application
5.5.2021EP Publication
5.7.2021Translation submitted
15.8.2021Registration published
1.3.2027Expires
Owner
Name:
Eisai R&D Management Co., Ltd.Address:
6-10, Koishikawa 4-chome, Bunkyo-ku, Tokyo 112-8088, JP
Inventor
Name:
ALBONE, Earl, F.Address:
Blue Bell PA 19422, US
Name:
CHENG, XinAddress:
Wallingford PA 19086, US
Name:
CUSTAR, Daniel, W.Address:
North Andover MA 01845, US
Name:
FURUUCHI, KeijiAddress:
Wynnewood PA 19096, US
Name:
LI, JingAddress:
Andover MA 01810, US
Name:
MAJUMDER, UtpalAddress:
Tewksbury, MA 01876, US
Name:
UENAKA, ToshimitsuAddress:
West Chester PA 19382, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662302562 PDate:
2.3.2016Country:
US
Classification
Categories:
A61K 47/68
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 18.2.2022
Expires: 1.3.2023
Payer: Patice ehf.
Number: 7
Paid: 20.2.2023
Expires: 1.3.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 28.2.2024
Expires: 1.3.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 11.2.2025
Expires: 1.3.2026
Payer: Árnason Faktor ehf.
Number: 10
Paid: 5.3.2026
Expires: 1.3.2027
Payer: Árnason Faktor ehf.